2021-12-23

Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease

Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease

Why do HPV tests with extended genotyping provide a more personalized assessment of an individual’s risk for developing cervical precancer? Discover the perspective of Molly Broache, Senior Manager, Medical Science Liaison at BD Life Sciences.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard
Women's Health STIs
Vaginitis | Brochures
Get her vaginitis diagnosis right the first time with the BD Vaginal Panel